UAE Neurology Clinical Trials Market Report 2022 to 2030

UAE Neurology Clinical Trials Market Analysis

$ 3999

UAE's Neurology Clinical Trials market is projected to grow from $26.2 Mn in 2022 to $43.3 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the modern healthcare infrastructure and a favorable regulatory environment that encourages investment in clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis, Pfizer, and Biogen.

ID: IN10AECT005 CATEGORY: Clinical Trials GEOGRAPHY: UAE AUTHOR: Vidhi Upadhyay

Buy Now

UAE Neurology Clinical Trials Market Executive Summary

UAE's Neurology Clinical Trials market is projected to grow from $26.2 Mn in 2022 to $43.3 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. It is predicted that the number of dementia patients in the UAE will grow by 1,795% by 2050. According to recent research published in the Lancet Public Health, the UAE and other Gulf nations will witness the greatest rise in the number of individuals living with dementia over the next 30 years. Stroke affects 8,000 to 10,000 people in the UAE each year, or one per hour.

Clinical trials in neurology are undertaken in the UAE for a variety of neurological disorders, including multiple sclerosis, Parkinson's disease, and Alzheimer's disease. These studies are carried out with the goal of increasing patient treatment choices and furthering our understanding of the fundamental processes of neurological illnesses. The UAE is quickly expanding its clinical trial business, which includes neurology. Many reasons are contributing to this rise, including the country's strategic position, contemporary healthcare infrastructure, and a favorable regulatory framework that fosters clinical research investment.

Numerous worldwide pharmaceutical and biotechnology firms, including Novartis, Pfizer, Biogen, and Sanofi, are conducting neurology clinical studies in the UAE. Moreover, numerous local hospitals and research institutions, including the Cleveland Clinic Abu Dhabi and the Dubai Health Authority, are undertaking neurological clinical trials. In January 2023, Abu Dhabi established a clinical trials center to advance medical research and assist promote the city as a worldwide medical center In collaboration with the Mayo Clinic, the center at Sheikh Shakhbout Medical City will explore remedies for ailments after standard therapies and drugs have failed.

UAE Neurology Clinical Trials Market

Market Dynamics

Market Growth Drivers

Over 400 clinical research studies are now underway in Abu Dhabi. Researchers may benefit from the UAE Genome Project, which strives to deliver preventative and personalised health care to the Emirati population, as well as the Malaffi system, which provides unified health services and patient information. The UAE has a contemporary healthcare infrastructure, a rising research community, and a regulatory framework that fosters investment in clinical research, all of which contribute to the rise of clinical trials. Moreover, the country's strategic position and huge patient population make it an appealing location for clinical trials.

Market Restraints

There are various barriers to the expansion of clinical trials in the UAE, including a dearth of competent healthcare professionals with clinical research competence, limited research funding, and the need for increased public knowledge and education about clinical trials. Moreover, regulatory and administrative constraints might be a problem, especially for international businesses conducting clinical trials in the UAE.

Competitive Landscape

Key Players

Novartis
Pfizer
Biogen
Sanofi
Eli Lilly and Company
AbbVie
Amgen
AstraZeneca
Merck & Co.
GlaxoSmithKline (GSK)

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Neurology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

Phase I
Phase II
Phase III
Phase IV

By Study Design Outlook (Revenue, USD Billion):

Epilepsy
Parkinson's Disease (PD)
Huntington's Disease
Stroke
Traumatic Brain Injury (TBI)
Amyotrophic Lateral Sclerosis (ALS)
Muscle regeneration
Others

By Indication Outlook (Revenue, USD Billion):

Interventional
Observational
Expanded Access

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.